- Home
- SAVA vs CURV Comparison
SAVA vs CURV Comparison
Compare SAVA & CURV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SAVA
- CURV
- Stock Information
- Founded
- SAVA 1998
- CURV 2001
- Country
- SAVA United States
- CURV United States
- Employees
- SAVA N/A
- CURV N/A
- Industry
- SAVA Biotechnology: Pharmaceutical Preparations
- CURV Clothing/Shoe/Accessory Stores
- Sector
- SAVA Health Care
- CURV Consumer Discretionary
- Exchange
- SAVA Nasdaq
- CURV Nasdaq
- Market Cap
- SAVA 213.0M
- CURV 185.4M
- IPO Year
- SAVA N/A
- CURV 2021
- Fundamental
- Price
- SAVA $3.82
- CURV $1.42
- Analyst Decision
- SAVA Buy
- CURV Hold
- Analyst Count
- SAVA 2
- CURV 6
- Target Price
- SAVA $5.00
- CURV $3.03
- AVG Volume (30 Days)
- SAVA 3.1M
- CURV 481.7K
- Earning Date
- SAVA 11-07-2025
- CURV 12-02-2025
- Dividend Yield
- SAVA N/A
- CURV N/A
- EPS Growth
- SAVA N/A
- CURV N/A
- EPS
- SAVA N/A
- CURV 0.03
- Revenue
- SAVA N/A
- CURV $1,068,099,000.00
- Revenue This Year
- SAVA N/A
- CURV N/A
- Revenue Next Year
- SAVA N/A
- CURV N/A
- P/E Ratio
- SAVA N/A
- CURV $47.86
- Revenue Growth
- SAVA N/A
- CURV N/A
- 52 Week Low
- SAVA $1.15
- CURV $1.39
- 52 Week High
- SAVA $33.98
- CURV $7.19
- Technical
- Relative Strength Index (RSI)
- SAVA 53.58
- CURV 33.06
- Support Level
- SAVA $3.62
- CURV $1.40
- Resistance Level
- SAVA $4.69
- CURV $1.80
- Average True Range (ATR)
- SAVA 0.39
- CURV 0.09
- MACD
- SAVA -0.08
- CURV 0.01
- Stochastic Oscillator
- SAVA 26.42
- CURV 18.18
About SAVA Cassava Sciences Inc.
Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease; and investigational diagnostic product candidate is called SavaDx and it is a novel way to detect the presence of Alzheimer's disease from a small sample of blood, possibly years before the overt appearance of clinical symptoms. It is currently conducting two randomized placebo-controlled Phase 3 clinical trials of oral simufilam in patients with Alzheimer's disease dementia. It has one business segment: the development of novel drugs and diagnostics.
About CURV Torrid Holdings Inc.
Torrid Holdings Inc is a direct-to-consumer brand of apparel, intimates, and accessories in North America. The company is focused on fit and offers high-quality products across a broad assortment that includes tops, bottoms, denim, dresses, intimates, activewear, footwear, and accessories. The company has one reportable segment, which includes the operation of the e-commerce platform and stores. The company generates revenue from the sale of apparel, intimates, and accessories through its e-commerce platform and its store locations.